Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2011 | 1 |
2012 | 2 |
2018 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
Lancet. 2018 Mar 31;391(10127):1263-1273. doi: 10.1016/S0140-6736(18)30475-6. Epub 2018 Mar 23.
Lancet. 2018.
PMID: 29576505
Clinical Trial.
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D; ASCEND investigators.
Kapoor R, et al.
Lancet Neurol. 2018 May;17(5):405-415. doi: 10.1016/S1474-4422(18)30069-3. Epub 2018 Mar 12.
Lancet Neurol. 2018.
PMID: 29545067
Clinical Trial.
Item in Clipboard
Value of carotid intima-media thickness and significant carotid stenosis as markers of stroke recurrence.
Roquer J, Segura T, Serena J, Cuadrado-Godia E, Blanco M, García-García J, Castillo J; ARTICO Study.
Roquer J, et al.
Stroke. 2011 Nov;42(11):3099-104. doi: 10.1161/STROKEAHA.110.612010. Epub 2011 Aug 18.
Stroke. 2011.
PMID: 21852617
Item in Clipboard
A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study.
Gómez-Isla T, Blesa R, Boada M, Clarimón J, Del Ser T, Domenech G, Ferro JM, Gómez-Ansón B, Manubens JM, Martínez-Lage JM, Muñoz D, Peña-Casanova J, Torres F; TRIMCI Study Group.
Gómez-Isla T, et al.
Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):21-9. doi: 10.1097/WAD.0b013e3181611024.
Alzheimer Dis Assoc Disord. 2008.
PMID: 18317243
Clinical Trial.
Item in Clipboard
Oxidative stress markers are associated to vascular recurrence in non-cardioembolic stroke patients non-treated with statins.
Brea D, Roquer J, Serena J, Segura T, Castillo J; ARTICO STUDY.
Brea D, et al.
BMC Neurol. 2012 Aug 3;12:65. doi: 10.1186/1471-2377-12-65.
BMC Neurol. 2012.
PMID: 22862793
Free PMC article.
Item in Clipboard
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators.
Coles AJ, et al.
Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1.
Lancet. 2012.
PMID: 23122650
Clinical Trial.
Item in Clipboard
Cite
Cite